BullFrog AI Holdings (BFRG) Operating Expenses (2022 - 2026)
BullFrog AI Holdings' (BFRG) quarterly Operating Expenses came in at $1.5 million in Q2 2026, up 3.37% on a YoY basis from $1.5 million in Q2 2025, and up 1.82% quarter-over-quarter from $1.5 million in Q4 2025.
Analysis
BullFrog AI Holdings (BFRG) Operating Expenses (2022 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRG) has reported Operating Expenses for 5 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Expenses rose 3.37% year-over-year to $1.5 million; the trailing twelve-month figure through Jun 2026 stood at $6.1 million (down 14.54% YoY), and the FY2025 full-year result was $6.6 million, down 8.57% from the prior year.
- Operating Expenses grew to $1.5 million in Q2 2026 per BFRG's latest filing, from $1.5 million in the prior quarter.
- Across five years, Operating Expenses topped out at $2.1 million in Q1 2025 and bottomed at $550251.0 in Q1 2022.
- Historically, Operating Expenses has averaged $1.4 million across 5 years, with a median of $1.5 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Operating Expenses soared 125.54% in 2023, then dropped 15.27% in 2025.
- Over 5 years, Operating Expenses stood at $592243.0 in 2022, then soared by 125.54% to $1.3 million in 2023, then surged by 32.42% to $1.8 million in 2024, then decreased by 15.27% to $1.5 million in 2025, then grew by 1.82% to $1.5 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $1.5 million, $1.5 million, and $1.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 6.54 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 18.20 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 2.09 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 3.00 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | -1.05 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 960.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.06 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 2.60 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 427.03 Mn |
| 10 | BullFrog AI Holdings | 9.27 Mn | 2.35 Mn | 106,899.00 | 1.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.53 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Dec 31, 2024 | 1.77 Mn |
| Sep 30, 2024 | 1.82 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 592,243.00 |
| Sep 30, 2022 | 640,552.00 |
| Jun 30, 2022 | 681,955.00 |
| Mar 31, 2022 | 550,251.00 |